Purchase Order HHSN275201600449P
Award Date 6/14/16
Potential Completion Date 7/21/16
Potential Value $12K
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Watertown, MA 02472, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services (HHS), to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The $80,000 contract is for the provision of testing services for 30 compounds, including conducting cytochrome P450 (CYP) inhibition testing, Caco-2 permeability assays, and other absorption, distribution, metabolism,...
- This firm fixed-price purchase order was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $157,158 contract is for the characterization of absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small-molecule drug candidates using standardized in vitro methods. This work supports...
- This is a $24,138.00 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The contract is for conducting testing of compounds in cytochrome P450 (CYP) inhibition assays. Cyprotex has previously been awarded prime federal contracts by agencies such as the Environmental Protection...
- This is a firm-fixed-price delivery order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The $203,550.00 contract is to provide high-throughput complex cell co-culture systems to support the EPA's toxicokinetics research program. This work involves rapidly generating absorption, distribution, metabolism, and excretion (ADME) data on hundreds of chemical compounds...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Cyprotex US LLC, a foreign-owned for-profit organization, for $153,215.00 to conduct testing of compounds in absorption, distribution, metabolism, and excretion (ADME) assays over a 1-year period from March 5, 2021 to March 4, 2022. The contract was awarded sole-source without full and open...
- This is a firm-fixed-price purchase order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $49,999.98 award is to conduct testing on chemicals using a network formation assay, supporting the EPA's chemical risk assessment efforts. Cyprotex specializes in predictive toxicology, absorption, distribution, metabolism, and excretion (ADME) research, and in vitro...
- This is a delivery order contract awarded by the U.S. Environmental Protection Agency (EPA) to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The $44,744 firm-fixed-price contract is for toxicokinetic testing services to support the EPA's High Throughput Toxicokinetics (HTTK) program, which aims to rapidly and cost-effectively generate toxicokinetic data on industrial chemicals and environmental contaminants. This contract is part of a larger $13 million...
- This firm-fixed-price Delivery Order contract, valued at $218,344.00, was awarded by the Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The contract is for the provision of a STEROIDOGENESIS ASSAY (ASSAY AND MULTIPLEXED ENDPOINT SAMPLE ANALYSIS) service, with an ultimate completion date of August 8, 2017. The contract has no set-aside designation. Cyprotex US LLC is a specialist in...
- This is a $50,000.00 firm-fixed-price purchase order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The contract is for testing of chemical compounds in a human neurite outgrowth assay as part of absorption, distribution, metabolism, and excretion (ADME) and toxicology (ADME-TOX) services. Cyprotex has significant expertise in predictive toxicology, ADME research, and in...
- This is a firm fixed price delivery order contract awarded by the Environmental Protection Agency (EPA) Office of Chemical Safety and Pollution Prevention to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $939,950.00 contract is for specialized toxicology services, including steroidogenesis assays and multiplexed endpoint sample analysis, to be performed at Cyprotex's facility in Watertown, Massachusetts. The contract is not set aside and is part of a...
This firm-fixed-price federal contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The $12,295.00 contract is for the provision of specialized testing services to support chemical risk assessment, drug development, and environmental research programs. Cyprotex has a significant Indefinite Delivery Indefinite Quantity (IDIQ) contract with the Environmental Protection Agency (EPA) for high-throughput toxicokinetics services, valued at $13 million over five years. This award to Cyprotex does not have a set-aside designation.
Generated 11/24/24, 9:33 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 6/14/16 |